CN1065529C - 4－喹啉酮衍生物及其盐 - Google Patents

4－喹啉酮衍生物及其盐 Download PDF

Info

Publication number
CN1065529C
CN1065529C CN95193500A CN95193500A CN1065529C CN 1065529 C CN1065529 C CN 1065529C CN 95193500 A CN95193500 A CN 95193500A CN 95193500 A CN95193500 A CN 95193500A CN 1065529 C CN1065529 C CN 1065529C
Authority
CN
China
Prior art keywords
carbon atom
alkyl
salt
compound
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN95193500A
Other languages
English (en)
Chinese (zh)
Other versions
CN1150420A (zh
Inventor
山崎和应
阿出川滋
小川阳一郎
松田秀明
仓石忠幸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Publication of CN1150420A publication Critical patent/CN1150420A/zh
Application granted granted Critical
Publication of CN1065529C publication Critical patent/CN1065529C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
CN95193500A 1994-06-09 1995-06-06 4－喹啉酮衍生物及其盐 Expired - Fee Related CN1065529C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP127573/94 1994-06-09
JP12757394 1994-06-09
JP127573/1994 1994-06-09

Publications (2)

Publication Number Publication Date
CN1150420A CN1150420A (zh) 1997-05-21
CN1065529C true CN1065529C (zh) 2001-05-09

Family

ID=14963397

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95193500A Expired - Fee Related CN1065529C (zh) 1994-06-09 1995-06-06 4－喹啉酮衍生物及其盐

Country Status (8)

Country Link
US (1) US5789419A (enExample)
EP (1) EP0764639A4 (enExample)
JP (1) JP3662929B2 (enExample)
KR (1) KR100254106B1 (enExample)
CN (1) CN1065529C (enExample)
CA (1) CA2191245A1 (enExample)
TW (1) TW308587B (enExample)
WO (1) WO1995033726A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294522B1 (en) 1999-12-03 2001-09-25 Cv Therapeutics, Inc. N6 heterocyclic 8-modified adenosine derivatives
US6605597B1 (en) * 1999-12-03 2003-08-12 Cv Therapeutics, Inc. Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivatives
SG186229A1 (en) 2010-06-07 2013-01-30 Novomedix Llc Furanyl compounds and the use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0298452A2 (de) * 1987-07-06 1989-01-11 F. Hoffmann-La Roche Ag In 4-Stellung durch Aryl oder N-Heteroaryl substituierte 2H-1-Benzopyran-Derivate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8414987D0 (en) * 1984-06-12 1984-07-18 Beecham Group Plc Active compounds
JPS61165760A (ja) * 1985-01-17 1986-07-26 Canon Inc 電子写真感光体
GB8916683D0 (en) * 1989-07-21 1989-09-06 Beecham Group Plc Novel compounds
TW224941B (enExample) * 1989-11-08 1994-06-11 Yamanouchi Pharma Co Ltd
US5175151A (en) * 1990-09-07 1992-12-29 Schering Corporation Antiviral compounds and antihypertensive compounds
US5401848A (en) * 1990-11-26 1995-03-28 E. R. Squibb & Sons, Inc. Indane and quinoline derivatives
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0298452A2 (de) * 1987-07-06 1989-01-11 F. Hoffmann-La Roche Ag In 4-Stellung durch Aryl oder N-Heteroaryl substituierte 2H-1-Benzopyran-Derivate

Also Published As

Publication number Publication date
TW308587B (enExample) 1997-06-21
KR100254106B1 (ko) 2000-05-01
JP3662929B2 (ja) 2005-06-22
KR970703316A (ko) 1997-07-03
WO1995033726A1 (en) 1995-12-14
US5789419A (en) 1998-08-04
EP0764639A1 (en) 1997-03-26
CN1150420A (zh) 1997-05-21
CA2191245A1 (en) 1995-12-14
EP0764639A4 (en) 1997-10-01

Similar Documents

Publication Publication Date Title
EP1133474B1 (en) 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
EP1919869B1 (fr) Dérivés de l'indole activateurs des ppar
SK283413B6 (sk) 2-Tioindoly, 2-indolíntióny a polysulfidy, ich selénové analógy a farmaceutické prostriedky na ich báze
CN1642910A (zh) 用于ah受体作为配体的吲哚噻唑化合物的合成
EP0210084A1 (fr) Amides, procédés pour leur préparation et médicaments les contenant
CN101677553A (zh) 苯并咪唑及其药物组合物
SI9111318A (en) Acetamide derivatives
EA008801B1 (ru) Получение арилалкилкарбаматных производных и их применение в терапии
WO2019196714A1 (zh) 作为dhodh抑制剂的n-取代丙烯酰胺衍生物及其制备和用途
JP2006063064A (ja) 受容体作動剤
JP2005522452A (ja) Ｃｎｓ疾患の治療のための、５−ｈｔ６受容体アフィニティーを有する７−アリールスルホンアミド−２，３，４，５−テトラヒドロ−１ｈ−ベンゾ’ジアゼピン誘導体
JPH09512542A (ja) Ｄ▲下４▼リセプタ拮抗剤としてのベンゾフラン誘導体
EP2055703A1 (en) Novel pyrimidine compound having benzyl(pyridylmethyl)amine structure and pharmaceutical comprising the compound
CN1033451C (zh) α-取代的苯甲胺衍生物
CN1429223A (zh) 新颖苯并呋喃衍生物
EP1765810B1 (en) 2,4-diaminoquinazolines for the treatment of spinal muscular atrophy
CN1065529C (zh) 4－喹啉酮衍生物及其盐
EP1572672B1 (en) Benzoxazocines and their use as monoamine-reuptake inhibitors
FR2512019A1 (fr) Derives de carbostyryle, leurs procedes de preparation et composition therapeutique les contenant
JP6943239B2 (ja) Ｋｃｎｑ２〜５チャネル活性化剤
EP0463944B1 (fr) Acyl benzoxazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
HK1049161A1 (en) Indole derivatives
CN1037179C (zh) 1,4－苯并噁嗪衍生物
EP0382628B1 (fr) Dérivés aminoalkoxyphényle, leur procédé de préparation ainsi que les compositions en contenant
KR20050102081A (ko) 3-치환된-4-아릴퀴놀린-2-온 유도체의 아트로프 이성체

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
FG4A Grant of patent
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee